# China NMPA Drug Inspection - Anguo City Qiao Traditional Chinese Medicine Pieces Co., Ltd. - Patchouli

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anguo-city-qiao-traditional-chinese-medicine-pieces-co-ltd/922bd7d5-92c0-4f5b-822d-95a05308a72c/
Source feed: China

> China NMPA drug inspection for Anguo City Qiao Traditional Chinese Medicine Pieces Co., Ltd. published January 21, 2020. Drug: Patchouli. The Shaanxi Provincial Drug Administration, operating under the broader National Medical Products Administration (NMPA) 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shaanxi Province Drug Quality Bulletin (2020, Issue 1, Serial No. 11)
- Company Name: Anguo City Qiao Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2020-01-21
- Drug Name: Patchouli
- Inspection Finding: 【examine】
- Action Taken: The relevant municipal (county, district) drug regulatory authorities have taken necessary control measures and are investigating and handling the matter in accordance with relevant laws and regulations.
- Summary: The Shaanxi Provincial Drug Administration, operating under the broader National Medical Products Administration (NMPA) framework, issued an announcement on January 21, 2020, detailing the results of its initial drug quality sampling inspection for the year. This proactive measure was undertaken to strengthen drug supervision and ensure public medication safety throughout the province.

The inspection identified ten batches of drugs that failed to meet quality standards. Manufacturers implicated include Gansu Hexi Pharmaceutical Co., Ltd., Anguo Shenghui Traditional Chinese Medicine Pieces Co., Ltd., Beijing Boaitang Anguo Traditional Chinese Medicine Technology Co., Ltd., Hubei Zhengguang Jiuzihe Pharmaceutical Co., Ltd., Shaanxi Kangchao Kangjian Pharmaceutical Co., Ltd., Shaanxi Duoyao Traditional Chinese Medicine Decoction Pieces Co., Ltd., Sichuan Tuojiangyuan Pharmaceutical Co., Ltd., and Anhui Pujian Traditional Chinese Medicine Pieces Co., Ltd.

The primary issues cited involved various quality attributes, specifically non-compliance in general analytical inspection parameters, physical properties (appearance), the quantity of extractable substances, and accurate content determination of active ingredients. These deficiencies were evaluated against official regulatory standards, including the Chinese Pharmacopoeia 2015 Edition, Ministry of Health Drug Standards, and Shaanxi Provincial Standards for Traditional Chinese Medicine Decoction Pieces.

Following these findings, relevant municipal drug regulatory departments have initiated necessary control measures for the involved entities. Further investigations are ongoing, and appropriate enforcement actions will be taken in accordance with applicable laws and regulations to rectify these quality lapses.

Company: https://www.globalkeysolutions.net/companies/anguo-city-qiao-traditional-chinese-medicine-pieces-co-ltd/8f64487c-3235-416c-a070-0de6d0531a84/